Pacira BioSciences Financials

Values in thousands	2024-09-30	2024-06-30	2024-03-31	2023-12-31
Revenue	$168,573	$178,023	$167,117	$181,244
Gross Profit	129,709	119,439	105,379	119,230
EBITDA	-139,527	49,838	35,382	52,451
EBIT		30,975	16,956	33,966
Net Income	-143,466	18,886	8,979	24,870
Net Change In Cash	168,573	178,023	167,117	181,244
Free Cash Flow	49,828	51,646	46,265	45,786
Cash	245,965	247,053	184,052	153,298
Basic Shares	46,134	50,539	52,193	52,064

Values in thousands	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Revenue	$674,978	$666,823	$541,533	$420,830
Gross Profit	490,309	467,528	401,278	303,502
EBITDA	162,897	144,779	118,472	71,424
EBIT	87,323	53,278	89,924	51,516
Net Income	41,955	15,909	41,980	145,523
Net Change In Cash	674,978	666,823	541,533	420,830
Cost of Revenue			485,621	21,729
Free Cash Flow	139,488	115,198	79,851	39,231
Cash	153,298	104,139	585,578	99,957
Basic Shares	51,979	46,538	45,630	43,682